Thermo Fisher Scientific Note payable to DIRECTV increased by 3.7% to $3.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $3.20B to $3.33B. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows an upward trend with a 7.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates higher short-term debt obligations to related parties, while a decrease reflects repayment or settlement of these specific liabilities. High levels may suggest reliance on related-party financing for working capital needs.
This represents a short-term financial obligation owed to a related party, specifically categorized as a current liabili...
Comparable to other 'Notes Payable to Related Parties' or 'Due to Affiliates' found in the current liabilities section of peer company balance sheets.
note_payable_directv| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.86B | $2.18B | $2.95B | $3.03B | $2.96B | $3.21B | $3.35B | $3.00B | $2.98B | $2.85B | $3.25B | $2.99B | $3.02B | $3.39B | $3.20B | $3.02B | $3.20B | $3.21B | $3.33B |
| QoQ Change | — | +16.9% | +35.6% | +2.8% | -2.5% | +8.4% | +4.6% | -10.7% | -0.7% | -4.3% | +14.0% | -8.0% | +1.1% | +12.4% | -5.7% | -5.5% | +5.9% | +0.3% | +3.7% |
| YoY Change | — | — | — | — | +58.9% | +47.4% | +13.7% | -1.2% | +0.6% | -11.2% | -3.2% | -0.3% | +1.5% | +19.1% | -1.4% | +1.2% | +6.0% | -5.4% | +4.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.